Sakara Digital https://validator.w3.org/feed/docs/rss2.html Let’s Connect Data Contracts in Pharma: Why Producers and Consumers Need Written Agreements MDM Vendor Selection for Mid-Cap Pharma: A 2026 Comparison Framework The Manufacturing Data Quality Scorecard: KPIs Beyond Regulatory Submissions Data Lineage Adoption in Clinical Data Management: Where Teams Stumble Real-World Data Governance for RWE Programs: A 2026 Framework Data Governance Council for Mid-Cap Biotech: A Charter Template Data Product Owner Role in Pharma: Job Description and 90-Day Onboarding Plan The Cost of Poor Data Quality in Pharma Manufacturing: A 2026 Benchmark Implementing Black Mesa GAIP in Mid-Cap Pharma: Common Objections and How to Handle Them FDA’s Software Precertification Program 2026: What Pharma AI Teams Should Track Validating GenAI for Regulatory Document Authoring: A Practical Playbook Annex 22 Post-Implementation Audit: The First 90 Days After Go-Live Human-in-the-Loop Requirements for Pharma AI: What FDA and EMA Actually Expect The Chief AI Ethics Officer for Pharma: When to Hire vs. Advise Building an AI Model Registry: What to Track and Why Consent Management for Patient AI Interactions: Framework and Templates Bias Testing in Pharma AI: Beyond the Demographics Checklist The AI Model Risk Assessment for Pharma: A Structured Checklist Legacy LIMS Modernization: A Three-Path Decision Framework Cloud Data Residency for Global Pharma: EU, US, and APAC Requirements Application Portfolio Rationalization Post-Merger: A 6-Month Playbook When Data Fabric Fails in Pharma: 5 Warning Signs from Real Deployments API-First Modernization in Regulated Pharma Environments Site Selection for Decentralized Trials: A 2026 Scoring Framework Real-World Evidence Platform Selection: A Buyer’s Guide Clinical Trial Data Standardization Beyond SDTM Site Payment Automation in Clinical Trials: A Pilot Program Framework Selecting a LIMS in 2026: What to Look For Beyond Features AI-Powered Literature Surveillance in Pharmacovigilance Patient Data Privacy in Clinical Research: Navigating GDPR and FDA Expectations Green Chemistry and Sustainable Manufacturing: Digital Tools for Pharma’s Environmental Transformation ATMP Manufacturing Automation: Scaling Cell and Gene Therapy Production Through Digital Innovation EU Gene Therapy Standards: Navigating EMA’s Evolving Manufacturing and Quality Requirements The Purolea Letter: What Pharma’s First AI Warning Means for GxP Compliance mRNA Manufacturing Technology: Digital Infrastructure for Next-Generation Vaccine and Therapeutic Production FDA Digital Health Precertification: Lessons Learned and the Path Forward for Software Developers Strategic Partnerships SAP S/4HANA Migration for Pharma: Planning the Transition Before 2027 End of Support Real-World Evidence Strategy: Building RWE Capabilities for Regulatory and Commercial Decision-Making Bioprocessing Digital Twins: Modeling Upstream and Downstream Operations for Process Optimization The Rise of the Electronic Trial Master File: From Digital Filing Cabinet to Compliance Intelligence Right-First-Time Manufacturing KPIs for Cell Therapy Sites AI Maturity Self-Assessment: A 30-Minute Diagnostic for Pharma IT Leaders Building a Digital-First Pharma Company: Lessons from Organizations Getting It Right Building a Right-First-Time Manufacturing Culture in Biopharma Supplier Quality Management for Pharma: What Good Looks Like in 2026 The DCT Hybrid Model That Actually Reduces Site Burden Adaptive Clinical Trial Designs in Rare Disease: When the Math Works How a Top-10 Pharma Validated Its First Production LLM in a GxP Environment (Public Case Pattern)